(Re-)introduction of TNF antagonists and JAK inhibitors in patients with previous tuberculosis: a systematic review.

Thomas Theo BrehmMaja ReimannNiklas KöhlerChristoph Lange

Published in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases (2024)

(Re-)initiation of TNF antagonists and JAK inhibitors may be relatively safe in patients with current or previous TB and the need for further treatment of underlying diseases.

Keyphrases

mycobacterium tuberculosis
rheumatoid arthritis
emergency department
hepatitis c virus
hiv infected
replacement therapy
human immunodeficiency virus
electronic health record
antiretroviral therapy